Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Study summary

This study uses questionnaires to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted health-related quality of life (HRQOL) and other areas such as COVID-19-specific psychological distress, disruptions to health care, finances and social interactions in cancer patients. The coronavirus disease 2019 (COVID-19) is an infectious disease that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The information learned from this study will guide the development of psychosocial programs to improve patient care and outcomes in cancer patients and survivors in the context of facing a global pandemic.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedQuality-of-Life Assessment and Questionnaire Administration

Plus 1 other study approaches.

Who it may be forCOVID-19 Infection · Malignant Solid Neoplasm

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 21, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?M.D. Anderson Cancer Center

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: M.D. Anderson Cancer Center
Interventions being studied: Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Other: Survey Administration

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Study topics

Survivorship and quality of life→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Prior patients who participated in one of the following protocols: 2012-0112, 2009-0976, or 2005-0035
Has an active email address or can be contacted via MyChart or personal email

Reasons someone may not be able to joinExclusion criteria

No evidence of consent from prior clinical trials

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

M D Anderson Cancer CenterHouston, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 21, 2026. Always confirm current availability with the study team.

View original record ↗